Cure8 research brief
Adherent-invasive E. coli (AIEC) is implicated in Crohn’s disease inflammation in some patients. This review maps possible ways to target AIEC specifically, which could lead to therapies that reduce infection-driven inflammation or complement current IBD treatments.
Adults with Crohn’s disease, clinicians treating IBD, researchers studying the microbiome and pathogen-targeted therapies, and patients interested in microbiome or diet-based interventions.
This open-access review summarizes current and emerging strategies to prevent or eliminate adherent-invasive Escherichia coli (AIEC) in Crohn’s disease, grouping approaches into four pillars: direct pathogen targeting (antibiotics, phage therapy), blockade of bacterial virulence factors (anti-adhesives, QseC inhibitors), host-mediated clearance (autophagy inducers), and ecological interventions/restoration (FMT, probiotics/prebiotics).
The article also discusses newer modalities such as predatory bacteria and siderophore immunization and synthesizes experimental and clinical evidence to outline future therapeutic ideas. The review is a literature synthesis (not a new clinical trial).
It appears to draw on laboratory, animal, and clinical studies to evaluate existing and proposed interventions against AIEC. The discussion includes both established treatments (antibiotics, dietary and microbiome-focused approaches) and investigational modalities (phage therapy, anti-virulence agents, immunization strategies).
This is a narrative review published in Gut Pathogens that synthesizes experimental and clinical literature; it does not report new trial results. Many proposed strategies are preclinical or early-stage; clinical efficacy and safety for most AIEC-targeted therapies remain to be established.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: The Priority Academic Program of Development Jiangsu High Education Institution, and the High-end Talent Program for International Collaboration, award S20250254
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The article connects psoriasis and Crohn's disease through shared immune pathways and the gut-skin axis, which may matter because people with one condition could have signs or risks related to the other. It emphasizes...
The article explains how gut bacteria may contribute to IBD and summarizes common tests and treatments people are likely to encounter. It highlights emerging microbial therapies (probiotics and FMT) that some patients...
This review spotlights non-bacterial members of the gut microbiota (viruses and fungi) that may contribute to IBD by altering barrier function, immune responses, and interactions with bacteria. For people with IBD, these...
